Inactive Instrument

Trivascular Technologies Inc Share Price

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

TriVascular Technologies, Inc. Reports Third Quarter Financial Results	09/11/15	GL
Preliminary Results of the LIFE Study Presented at VIVA 2015	03/11/15	GL
Four-Year Results From Global Ovation Pivotal Trial Presented at VIVA 2015	03/11/15	GL
Trivascular Technologies : Brower Piven Commences An Investigation Into The Proposed Sale Of TriVascular Technologies, Inc. And Encourages Investors To Contact The Firm For Additional Information	29/10/15	BU
TRIVASCULAR TECHNOLOGIES : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Acquisition by Endologix, Inc. May be Unfair to Shareholders	28/10/15	BU

Managers	Title	Age	Since
John Onopchenko CEO	Chief Executive Officer	66	-
Vaseem Mahboob DFI	Director of Finance/CFO	55	02/02/16

Sector

	1st Jan change	Capi.
STRYKER CORPORATION	+9.96%	127B
SMITH & NEPHEW PLC	-6.58%	10.91B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+2.70%	9.24B
INSPIRE MEDICAL SYSTEMS, INC.	-19.67%	7.44B
GLAUKOS CORPORATION	+34.49%	5.44B
AXONICS, INC.	+8.18%	3.44B
ENOVIS CORPORATION	-9.55%	2.87B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-5.57%	2.25B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-0.60%	2.23B